Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: Differences between Chinese women and women in Western countries and possible mechanisms
Tài liệu tham khảo
Ziegler, 2008, Increasing breast cancer incidence in China: the numbers add up, J. Natl. Cancer Inst., 100, 1339, 10.1093/jnci/djn330
Murtaugh, 2008, Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study, Am. J. Clin. Nutr., 87, 978, 10.1093/ajcn/87.4.978
Perry, 2009, Risk factors for breast cancer in East Asian women relative to women in the West, Asia-Pacific J. Clin. Oncol., 5, 219, 10.1111/j.1743-7563.2009.01242.x
Qiu, 2010, The origin and history of soybean
Li, 2008, Genetic structure and diversity of cultivated soybean (Glycine max (L.) Merr.) landraces in China, Theor. Appl. Genet., 117, 857, 10.1007/s00122-008-0825-0
2013
2012
Orf, 2013
2013
2010
Zambiazi, 2007, Fatty acid composition of vegetable oils and fats, B. CEPPA, Curitiba, 25, 111
Hoffman, 2004, Protein – which is best?, J. Sports Sci. Med., 3, 118
2013
Anderson, 1995, Meta-analysis of the effects of soy protein intake on serum lipids, N. Engl. J. Med., 333, 276, 10.1056/NEJM199508033330502
Crouse, 1999, A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins, Arch. Intern. Med., 159, 2070, 10.1001/archinte.159.17.2070
Sitori, 1997, Role of isoflavones in the cholesterol reduction of soy proteins in the clinic. Letter to the editor, Am. J. Clin. Nutr., 65, 166, 10.1093/ajcn/65.1.166
Food and Drug Administration, 1999, vol. 64 (64)
Hermansen, 2003, Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: a literature review, Adv. Ther., 20, 50, 10.1007/BF02850119
Sacks, 2006, Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee, Circulation, 113, 1034, 10.1161/CIRCULATIONAHA.106.171052
Webb, 2010, Shedding light on soy, Today's Dietitian, 12, 28
2013
2013
2013
Lazor, 2010, Soy goes to school: acceptance of healthful, vegetarian options in Maryland middle school lunches, J. Sch. Helath, 80, 200, 10.1111/j.1746-1561.2009.00487.x
2012
M. Messina, J.W. Erdman, Jr. (Guest Editors), in: First International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Proceedings from a Symposium Held in Mesa, Arizona on February 20–23, 1994, J. Nutr. Suppl., 1995.
Messina, 2009, J. Nutr., 796S, 10.3945/jn.108.104182
2013
2013
2013
Growmwell, 1999, Soybean meal – the “Gold Standard”, The Farmer's Pride, KPPA News, 11
Shurtleff, 2007
Shigeki, 2008, Identification of two major ammonia-releasing reactions involved in secondary natto fermentation, Biosci. Biotechnol. Biochem., 72, 1869, 10.1271/bbb.80129
Shurtleff, 1985
Liem, 1977, Production of vitamin B-12 in tempeh, a fermented soybean food, Appl. Environ. Microbiol., 773, 10.1128/AEM.34.6.773-776.1977
Shurtleff, 2010
Shurtleff, 2012
Sugiyama, 1984, Selection of micro-organisms for use in the fermentation of soy sauce, Food Microbiol., 1, 339, 10.1016/0740-0020(84)90067-4
2013
Galeaz, 2013
Jefferson, 2003, Dietary phytoestrogens – a role in womens health, Nutr. Food Sci., 33, 16, 10.1108/00346650310459527
Liu, 2012, Developing phytoestrogens for breast cancer prevention, Anticancer Agents Med. Chem., 12, 1306, 10.2174/187152012803833062
Kaufman, 1997, A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health, J. Altern. Complement. Med., 3, 7, 10.1089/acm.1997.3.7
Murphy, 1999, Isoflavones in retail and institutional soy foods, J. Agric. Food Chem., 47, 2697, 10.1021/jf981144o
Wang, 1994, Isoflavone content in commercial soybean foods, J. Agric. Food Chem., 42, 1666, 10.1021/jf00044a016
Kim, 2005, Changing soybean isoflavone composition and concentrations under two different storage conditions over three years, Food Res. Int., 38, 435, 10.1016/j.foodres.2004.11.001
Seguin, 2004, Isoflavone content of soybean cultivars grown in eastern Canada, J. Sci. Food Agric., 84, 1327, 10.1002/jsfa.1825
Sertovic, 2012, Effect of soybean cultivars on the content of isoflavones in soymilk Romanian, Biotechnol. Lett., 17, 7151
Bhagwat, 2008, 25
Winkel-Shirley, 2001, Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology, Plant Physiol., 126, 485, 10.1104/pp.126.2.485
Rossi, 2010, Dietary isoflavones and intestinal microbiota: metabolism and transformation into bioactive compounds, 137
Boik, 1996
Badger, 2009, The health implications of soy infant formula, Am. J. Clin. Nutr., 89, 1668S, 10.3945/ajcn.2009.26736U
Yuan, 2007, Metabolism of dietary soy isoflavones to equol by human intestinal microflora – implications for health, Mol. Nutr. Food Res., 51, 765, 10.1002/mnfr.200600262
Song, 2006, Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls, J. Nutr., 136, 1347, 10.1093/jn/136.5.1347
Youlden, 2012, The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality, Cancer Epidemiol., 36, 237, 10.1016/j.canep.2012.02.007
Kerrie, 2000, Genistein: does it prevent or promote breast cancer?, Environ. Health Perspect., 108, 701, 10.1289/ehp.00108701
Wu, 1996, Tofu and risk of breast cancer in Asian-Americans, Cancer Epidemiol. Biomarkers Prev., 5, 901
Furberg, 2001, Tumor characteristics in African American and White women, Breast Cancer Res. Treat., 68, 33, 10.1023/A:1017994726207
Middleton, 2003, Histopathology of breast cancer among African-American women, Cancer, 97, 253, 10.1002/cncr.11021
Newman, 2002, Ethnicity related differences in the survival of young breast carcinoma patients, Cancer, 95, 21, 10.1002/cncr.10639
Chen, 2013, Incidence and mortality of breast cancer in China, 2008, Thoracic Cancer, 4, 59, 10.1111/j.1759-7714.2012.00165.x
Linos, 2008, Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis, J. Natl. Cancer Inst., 100, 1352, 10.1093/jnci/djn305
Shin, 2010, Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women, Cancer Causes Control, 21, 1777, 10.1007/s10552-010-9604-8
Goldin, 1986, The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women, Am. J. Clin. Nutr., 44, 945, 10.1093/ajcn/44.6.945
Pinheiro, 2005, Racial differences in premenopausal endogenous hormones, Cancer Epidemiol. Biomarkers Prev., 14, 2147, 10.1158/1055-9965.EPI-04-0944
Yager, 2006, Estrogen carcinogenesis in breast cancer, N. Engl. J. Med., 354, 270, 10.1056/NEJMra050776
Qin, 2006, Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies, J. Nutr. Sci. Vitaminol. (Tokyo), 52, 428, 10.3177/jnsv.52.428
Guha, 2009, Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the life after cancer epidemiology study, Breast Cancer Res. Treat., 118, 395, 10.1007/s10549-009-0321-5
Shu, 2009, Soy food intake and breast cancer survival, JAMA, 302, 2437, 10.1001/jama.2009.1783
Kang, 2010, Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy, Can. Med. Assoc. J., 182, 1857, 10.1503/cmaj.091298
Zhang, 2010, Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status, Cancer Sci., 101, 501, 10.1111/j.1349-7006.2009.01376.x
Zhu, 2011, Relationship between soy food intake and breast cancer in China, Asian Pac. J. Cancer Prev., 12, 2837
Kang, 2012, Study on soy isoflavone consumption and risk of breast cancer and survival, Asian Pac. J. Cancer Prev., 13, 995, 10.7314/APJCP.2012.13.3.995
Zhang, 2012, Positive effects of soy isoflavone food on survival of breast cancer patients in China, Asian Pac. J. Cancer Prev., 13, 479, 10.7314/APJCP.2012.13.2.479
Dong, 2011, Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies, Breast Cancer Res. Treat., 125, 315, 10.1007/s10549-010-1270-8
Nechuta, 2012, Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women, Am. J. Clin. Nutr., 96, 123, 10.3945/ajcn.112.035972
Magee, 2012, Soy products in the management of breast cancer, Curr. Opin. Clin. Nutr. Metab. Care, 15, 586, 10.1097/MCO.0b013e328359156f
Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta, Endocrinology, 139, 4252, 10.1210/endo.139.10.6216
Ju, 2006, Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations, Carcinogenesis, 27, 1292, 10.1093/carcin/bgi370
Chen, 2004, Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells, J. Clin. Endocrinol. Metab., 89, 2351, 10.1210/jc.2003-032065
Yang, 2010, Genistein induces enhanced growth promotion in ER-positive/erbB-2-overexpressing breast cancers by ER-erbB-2 cross talk and p27/kip1 downregulation, Carcinogenesis, 31, 695, 10.1093/carcin/bgq007
Helferich, 2008, Phytoestrogens and breast cancer: a complex story, Inflammopharmacology, 16, 219, 10.1007/s10787-008-8020-0
Tonetti, 2007, The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha, Nutr. Cancer, 58, 222, 10.1080/01635580701328545
Jiang, 2008, Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells, Endocrinology, 149, 5366, 10.1210/en.2008-0857
Wood, 2007, Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys, Carcinogenesis, 28, 801, 10.1093/carcin/bgl163
Leung, 2006, Estrogen receptor (ER)-β isoforms: a key to understanding ER-β signaling, Proc. Natl. Acad. Sci. U.S.A., 103, 13162, 10.1073/pnas.0605676103
Leung, 2012, Estrogen receptor-beta and breast cancer: translating biology into clinical practice, Steroids, 77, 727, 10.1016/j.steroids.2012.03.008
Cappelletti, 2006, Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells, J. Oncol., 28, 1185
Bird, 2007, Perceptions of epigenetics, Nature, 447, 396, 10.1038/nature05913
Suzuki, 2008, A DNA methylation landscapes: provocative insights from epigenomics, Nat. Rev. Genet., 9, 465, 10.1038/nrg2341
Li, 2013, Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer, Mol. Cancer, 4, 12
Fürst, 2012, A differentially methylated single CpG-site is correlated with estrogen receptor alpha transcription, J. Steroid Biochem. Mol. Biol., 130, 96, 10.1016/j.jsbmb.2012.01.009
Yoshida, 2000, Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors, Carcinogenesis, 21, 2193, 10.1093/carcin/21.12.2193
Wei, 2012, Promoter methylation status and expression of estrogen receptor alpha in familial breast cancer patients, Tumour Biol., 33, 413, 10.1007/s13277-011-0234-x
Li, 2013, Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein, PLoS ONE, 8, e5436
Gertz, 2012, Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner, Genome Res., 22, 2153, 10.1101/gr.135681.111
Zhang, 2012, Effects of soy isoflavone and endogenous oestrogen on breast cancer in MMTV-erbB2 transgenic mice, J. Int. Med. Res., 40, 2073, 10.1177/030006051204000604
Michalik, 2006, International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors, Pharmacol. Rev., 58, 726, 10.1124/pr.58.4.5
Belfiore, 2009, PPAR-gamma agonists and their effects on IGF-I receptor signaling: implications for cancer, PPAR Res., 830501
Berger, 2002, The mechanisms of action of PPARs, Annu. Rev. Med., 53, 409, 10.1146/annurev.med.53.082901.104018
Feige, 2006, From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions, Prog. Lipid Res., 45, 120, 10.1016/j.plipres.2005.12.002
Dang, 2003, Peroxisome proliferator-activated receptor g (PPARg) as a molecular target for the soy phytoestrogen genistein, J. Biol. Chem., 278, 962, 10.1074/jbc.M209483200
Dang, 2005, Dose-dependent effects of phytoestrogens on bone: molecular mechanisms, Trends Endocrinol. Metabol., 16, 207, 10.1016/j.tem.2005.05.001
Dang, 2009, Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: mechanisms of action, Obes. Rev., 10, 342, 10.1111/j.1467-789X.2008.00554.x
D. Green, Means to an end: apoptosis and other cell death mechanisms, Cold Spring Harbor Laboratory Press, New York.
Shim, 2007, Genistein-induced apoptosis of human breast cancer MCF-7 cells involves calpain-caspase and apoptosis signaling kinase 1-p38 mitogen-activated protein kinase activation cascades, Anticancer Drugs, 18, 649, 10.1097/CAD.0b013e3280825573
Ferenc, 2010, Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells, J. Photochem. Photobiol. B, 98, 25, 10.1016/j.jphotobiol.2009.10.004
Li, 2008, Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway, Toxicol. In Vitro, 22, 1749, 10.1016/j.tiv.2008.08.001
Pan, 2012, Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway, Int. J. Mol. Med., 30, 337, 10.3892/ijmm.2012.990
Zhu, 2013, Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer, Am. J. Cancer Res., 3, 230
Zhou, 2012, Autophagy in tumorigenesis and cancer therapy: Dr Jekyll or Mr Hyde?, Cancer Lett., 323, 115, 10.1016/j.canlet.2012.02.017
Lin, 2013, Autophagy regulates TNFα-mediated joint destruction in experimental arthritis, Ann. Rheum. Dis., 72, 761, 10.1136/annrheumdis-2012-201671
Schwartz, 1993, Do all programmed cell deaths occur via apoptosis?, Proc. Natl. Acad. Sci. U.S.A., 90, 980, 10.1073/pnas.90.3.980
Mathew, 2009, Autophagy suppresses tumorigenesis through elimination of p62, Cell, 137, 1062, 10.1016/j.cell.2009.03.048
Gossner, 2007, Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells, Gynecol. Oncol., 105, 23, 10.1016/j.ygyno.2006.11.009
Singletary, 2008, Diet, autophagy, and cancer: a review, Cancer Epidemiol. Biomarkers Prev., 17, 1596, 10.1158/1055-9965.EPI-07-2917
Nakamura, 2009, A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy, Mol. Cancer, 8, 100, 10.1186/1476-4598-8-100
Pan, 2013, Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells, PLoS ONE, 8, e56679, 10.1371/journal.pone.0056679
Karantza, 2007, Role of autophagy in breast cancer, Autophagy, 3, 610, 10.4161/auto.4867
Li, 2012, JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells, Toxicol. Appl. Pharmacol., 263, 21, 10.1016/j.taap.2012.05.018